Polypoidal Choroidal Vasculopathy: Clinical Trials

1 trial for Polypoidal Choroidal Vasculopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)
Faricimab Injection [Vabysmo] - Polypoidal Choroidal Vasculopathy
Phase 4RecruitingAssociation for Innovation and Biomedical Research on Light and Image1202025-08-062026-02-06

Broader conditions

Choroid Diseases (1)  ·  Choroidal Neovascularization (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Uveal Diseases (1)

Interventions

faricimab (1)

Sponsors

Association for Innovation and Biomedical Research on Light and Image (1)

Countries

Italy (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Kingdom (1)

Results publications

PMID 42054086